Adma Biologics

Ticker ADMA

Exchange NASDAQ More
Industry Biotechnology More
Sector Healthcare More

51-200 Employees
Based in Ramsey, New Jersey

ADMA is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of Primary Immune Deficiency Disease (PIDD) and certain infectious diseases.

Social Media Links

REPORT RATINGS

4.8 / 5.0 (208)

Adma Biologics reports have an aggregate usefulness score of 4.8 based on 208 reviews.

Adma Biologics

Most Recent Annual Report

MOST RECENT 2023 Annual Report and Form 10K

View PDF View Form 10K (HTML)

Adma Biologics does not currently have any hardcopy reports on 博九娱乐网. Click the button below to request a report when hardcopies become available.

Please fill out the form below and click "Place Order" to complete your order.

Request Information

Older/Archived Annual Reports

2022 Annual Report View Annual Report Download
2021 Annual Report View Annual Report Download
2020 Annual Report View Annual Report Download
2019 Annual Report View Annual Report Download
2018 Annual Report View Annual Report Download
2017 Annual Report View Annual Report Download
2016 Annual Report View Annual Report Download
2015 Annual Report View Annual Report Download
2014 Annual Report View Annual Report Download
2013 Annual Report View Annual Report Download
2012 Annual Report View Annual Report Download

Show 8 older reports

博九娱乐网

Adma Biologics

Most Recent Annual Report

Older/Archived Annual Reports

Rate This Report